ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,860,000 | +37.1% | 22,430 | 0.0% | 0.02% | +41.7% |
| Q2 2021 | $2,815,000 | -7.5% | 22,430 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $3,042,000 | +6.0% | 22,430 | 0.0% | 0.01% | +18.2% |
| Q4 2020 | $2,870,000 | -0.5% | 22,430 | -12.5% | 0.01% | -8.3% |
| Q3 2020 | $2,885,000 | +12.2% | 25,640 | -5.0% | 0.01% | +9.1% |
| Q2 2020 | $2,572,000 | +6.0% | 27,000 | 0.0% | 0.01% | -26.7% |
| Q1 2020 | $2,426,000 | -26.8% | 27,000 | -67.8% | 0.02% | -34.8% |
| Q3 2019 | $3,315,000 | -3.8% | 83,900 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $3,447,000 | -11.8% | 83,900 | 0.0% | 0.02% | -8.0% |
| Q1 2019 | $3,907,000 | +6.9% | 83,900 | 0.0% | 0.02% | -16.7% |
| Q4 2018 | $3,654,000 | -23.9% | 83,900 | 0.0% | 0.03% | -6.2% |
| Q3 2018 | $4,802,000 | -39.6% | 83,900 | -48.8% | 0.03% | -46.7% |
| Q2 2018 | $7,952,000 | +24.1% | 163,900 | 0.0% | 0.06% | +11.1% |
| Q1 2018 | $6,408,000 | -7.9% | 163,900 | 0.0% | 0.05% | -10.0% |
| Q4 2017 | $6,956,000 | +13.7% | 163,900 | 0.0% | 0.06% | +20.0% |
| Q3 2017 | $6,117,000 | +599.9% | 163,900 | +469.8% | 0.05% | +525.0% |
| Q2 2017 | $874,000 | +14.8% | 28,765 | 0.0% | 0.01% | +33.3% |
| Q1 2017 | $761,000 | +3.7% | 28,765 | 0.0% | 0.01% | -14.3% |
| Q4 2016 | $734,000 | -29.5% | 28,765 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $1,041,000 | +6.6% | 28,765 | 0.0% | 0.01% | -10.0% |
| Q2 2016 | $977,000 | +28.7% | 28,765 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $759,000 | -45.9% | 28,765 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $1,403,000 | +95.9% | 28,765 | 0.0% | 0.01% | +71.4% |
| Q3 2015 | $716,000 | -21.3% | 28,765 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $910,000 | -16.9% | 28,765 | 0.0% | 0.01% | -11.1% |
| Q1 2015 | $1,095,000 | -2.3% | 28,765 | 0.0% | 0.01% | -18.2% |
| Q4 2014 | $1,121,000 | +28.9% | 28,765 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $870,000 | -11.0% | 28,765 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $977,000 | -1.5% | 28,765 | 0.0% | 0.01% | -7.7% |
| Q1 2014 | $992,000 | -16.5% | 28,765 | -4.1% | 0.01% | -23.5% |
| Q4 2013 | $1,188,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |